2020
DOI: 10.1007/978-981-15-1671-9_23
|View full text |Cite
|
Sign up to set email alerts
|

Small Interfering RNAs and RNA Therapeutics in Cardiovascular Diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 89 publications
0
1
0
Order By: Relevance
“…In addition, in humans, small RNAs have been associated with various pathologies, such as some types of cancer [ 10 ], celiac disease [ 16 ], acute myocardial infarction (AMI) [ 17 ], and CVDs in general [ 18 ], among others. For this reason, some small RNAs that can be used as biomarkers and for interference (therapeutic level) to be applied in CVDs have already been proposed; however, more studies are needed to ensure their viability and feasibility of use [ 17 , 18 , 19 ].…”
Section: Introductionmentioning
confidence: 99%
“…In addition, in humans, small RNAs have been associated with various pathologies, such as some types of cancer [ 10 ], celiac disease [ 16 ], acute myocardial infarction (AMI) [ 17 ], and CVDs in general [ 18 ], among others. For this reason, some small RNAs that can be used as biomarkers and for interference (therapeutic level) to be applied in CVDs have already been proposed; however, more studies are needed to ensure their viability and feasibility of use [ 17 , 18 , 19 ].…”
Section: Introductionmentioning
confidence: 99%